The aim of this study was to evaluate the validity of Osteocalcin (OCN) and Alkaline Phosphatase (ALP) immunohistochemistry in discriminating OSA from OPBT. The gene discussed is BGLAP; the disease is obstructive sleep apnea syndrome.